INS and breast carcinoma: Studies of osteoblasts [21], breast cancer cells [22], endothelial cells [20], and of particular relevance, brown adipocytes [23] have shown that genetic reduction of IGF-1 R expression enhances insulin sensitivity, indicating that the insulin-generated signal is negatively regulated by an interaction with the IGF-1 R.